Contract for the supply of Td/IPV
key details
| Status | complete |
|---|---|
| Category (CPV) | 33650000 |
| Region | Scotland, Wales, Northern Ireland |
| Deadline | 27 Oct 2016 |
| Contract start | 1 Oct 2017 |
| Contract end | 30 Sept 2021 |
| Procedure | open |
| SME suitable | No |
| OCID | ocds-b5fd17-3ef21060-adca-11e6-9901-0019b9f3037b |
Award
| Supplier | Value | Date | Status |
|---|---|---|---|
| Sanofi Pasteur MSD | £0 | 2 Dec 2016 | active |
description
The provision of low dose diphtheria, tetanus and inactivated polio vaccine (Td/IPV), to be used as part of the national childhood immunisation programme. The contracting authority estimates their requirement over the period of the contract, including the period of the optional extension to be up to 4,600,00 doses of vaccine. The opportunity is not being split into lots as there is only one supplier that holds a marketing authorisation for this product.
documents
- https://www.contractsfinder.service.gov.uk/Notice/281f22dd-017b-4fd9-b8b8-9d2cf434d16f , tenderNotice
- https://www.contractsfinder.service.gov.uk/Notice/Attachment/53dadb45-a841-4144-882d-a8d363b5f051 , application/x-zip-compressed
- https://www.contractsfinder.service.gov.uk/Notice/Attachment/ead1c6fb-98dd-4ada-98d6-ef89b7a10831 , application/pdf
Documents are linked, not mirrored. They are served by the publishing authority and may require registration.
notice history
1 notice published against this procurement.
| Published | Type | Regime | Notice |
|---|---|---|---|
| 22 Dec 2016 | Award update (awardUpdate) | · | 6425e0f9-4315-4c6e-8dce-33c2ff28ba2b-122401 |
more from COMMERCIAL MEDICINES UNIT
- NHS Framework Agreement for Branded Pharmaceuticals - North of England Tranche A. · £575,675,600 · 24 Apr 2017
- NHS Framework Agreement for the Midlands and East Pharmacy Purchasing Group for the supply of Proprietary Pharmaceuticals - Tranche B · £102,379,487 · 24 Apr 2017
- Contract for the supply of BCG vaccine · 9 Jan 2017
- Contract for the supply of human papillomavrius vaccine · 22 Dec 2016
- NHS National Pharmaceuticals - Wave 10c Offer reference number: CM/PHG/15/5466 Period of framework agreement: Dates detailed below with options to extend up to a maximum period of 40 months. Potential periods of call-offs under the framework agreement: Oral Products: All Regions 01/07/2017 to 28/02/2019 (20 months) Hospital Only Products: Central and South West (CESW) 01/07/2017 to 30/06/2018 (12 months); North West and Eastern and North London (NWLN) 01/07/2017 to 30/06/2018 (12 months) and South East and South London and North East and Yorkshire (LSNE) 01/07/2017 to 30/06/2018 (12 months) · £182,500,000 · 16 Dec 2016
- NHS Framework Agreement for Hepatitis C Medicines for Midlands and East and North of England regions · £85,000,000 · 25 Nov 2016
- Invitation to offer for NHS Framework Agreement for Branded Pharmaceuticals for London – Tranche A (inc. Hepatitis C) · £201,544,684 · 18 Nov 2016
- Contract for the supply of BCG vaccine · 18 Nov 2016
all contracts from this buyer →
similar contracts awarded
Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.
- Provision of a new antimicrobial to the NHS in England via a subscription-based payment model · NHS England
- Provision of an Existing Antimicrobial to the NHS in England via a Subscription-based Payment Model · NHS England
source
Published on Contracts Finder. Contact details for named individuals are not reproduced on this site.